Therma Bright Inc (TBRIF)

$0.01 0.00 (-1.10%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 51,900
Avg Vol 137,786
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 23%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Therma Bright Inc. acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace. The company's products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; Benepod, a hot and cold contrast therapy device fo...

Industry: Medical Devices
Sector: Healthcare
Phone: 844 274 6837
Address:
345 Danforth Avenue, Toronto, Canada
newsfile_corp
newsfile_corp Jun. 11 at 10:31 AM
https://nfne.ws/255196 $TBRIF $THRM.TSXV @bright_therma #AIDigitalCoughTechnology #Benepod #InStatin #Interceptcs #Venowave #Chemicals #Bio
0 · Reply
newsfile_corp
newsfile_corp Jun. 5 at 11:13 AM
https://nfne.ws/254584 $TBRIF $THRM.TSXV @bright_therma #AIDigitalCoughTechnology #benepod #InStatin #interceptcs #venowave #Chemicals #Bio
0 · Reply
PsychedStocks
PsychedStocks May. 13 at 4:00 PM
$TBRIF Therma Bright is quietly building a diversified IP portfolio — from AI-powered infection detection to FDA-cleared thermal imaging. Positioned to benefit from real revenue, not just biotech hype. Undervalued vs peers, execution is the next catalyst. $MMAT $PFE $SPY $HCWB
1 · Reply
PsychedStocks
PsychedStocks May. 8 at 11:50 AM
$TBRIF $MDXG $EMED $BLFS $MMAT Therma Bright Inc. Provides Update on InStatin Development, Announcement of Key Strategic Advisor and Highlights Preclinical and IP Progress at InStatin https://www.newsfilecorp.com/release/251233
0 · Reply
Stock__Shark
Stock__Shark May. 8 at 11:41 AM
$TBRIF
0 · Reply
newsfile_corp
newsfile_corp May. 8 at 10:31 AM
https://nfne.ws/251233 $TBRIF $THRM.TSXV @bright_therma #AIDigitalCoughTechnology #Inretio #InStatin #InterceptCS #Venowave #Chemicals #Bio
0 · Reply
Stock__Shark
Stock__Shark May. 7 at 5:24 PM
$TBRIF $MDXG $EMED $BLFS $MMAT
0 · Reply
PsychedStocks
PsychedStocks May. 7 at 4:37 PM
$TBRIF Spinning off consumer product portfolio into separate public company by H1 2025 FDA 510K approval for Venowave VW5 unlocks Medicare/Medicaid reimbursement market Revolutionizing vascular health with innovative medical devices and nationwide distribution $MDXG $EMED $BLFS $MMAT
0 · Reply
PsychedStocks
PsychedStocks Apr. 25 at 1:11 PM
$CYBN $CYBHF $TBRIF
0 · Reply
Stock__Shark
Stock__Shark Apr. 24 at 1:32 PM
$TBRIF
0 · Reply
Latest News on TBRIF
No data available.
newsfile_corp
newsfile_corp Jun. 11 at 10:31 AM
https://nfne.ws/255196 $TBRIF $THRM.TSXV @bright_therma #AIDigitalCoughTechnology #Benepod #InStatin #Interceptcs #Venowave #Chemicals #Bio
0 · Reply
newsfile_corp
newsfile_corp Jun. 5 at 11:13 AM
https://nfne.ws/254584 $TBRIF $THRM.TSXV @bright_therma #AIDigitalCoughTechnology #benepod #InStatin #interceptcs #venowave #Chemicals #Bio
0 · Reply
PsychedStocks
PsychedStocks May. 13 at 4:00 PM
$TBRIF Therma Bright is quietly building a diversified IP portfolio — from AI-powered infection detection to FDA-cleared thermal imaging. Positioned to benefit from real revenue, not just biotech hype. Undervalued vs peers, execution is the next catalyst. $MMAT $PFE $SPY $HCWB
1 · Reply
PsychedStocks
PsychedStocks May. 8 at 11:50 AM
$TBRIF $MDXG $EMED $BLFS $MMAT Therma Bright Inc. Provides Update on InStatin Development, Announcement of Key Strategic Advisor and Highlights Preclinical and IP Progress at InStatin https://www.newsfilecorp.com/release/251233
0 · Reply
Stock__Shark
Stock__Shark May. 8 at 11:41 AM
$TBRIF
0 · Reply
newsfile_corp
newsfile_corp May. 8 at 10:31 AM
https://nfne.ws/251233 $TBRIF $THRM.TSXV @bright_therma #AIDigitalCoughTechnology #Inretio #InStatin #InterceptCS #Venowave #Chemicals #Bio
0 · Reply
Stock__Shark
Stock__Shark May. 7 at 5:24 PM
$TBRIF $MDXG $EMED $BLFS $MMAT
0 · Reply
PsychedStocks
PsychedStocks May. 7 at 4:37 PM
$TBRIF Spinning off consumer product portfolio into separate public company by H1 2025 FDA 510K approval for Venowave VW5 unlocks Medicare/Medicaid reimbursement market Revolutionizing vascular health with innovative medical devices and nationwide distribution $MDXG $EMED $BLFS $MMAT
0 · Reply
PsychedStocks
PsychedStocks Apr. 25 at 1:11 PM
$CYBN $CYBHF $TBRIF
0 · Reply
Stock__Shark
Stock__Shark Apr. 24 at 1:32 PM
$TBRIF
0 · Reply
PsychedStocks
PsychedStocks Apr. 24 at 1:25 PM
$TBRIF $MRNA $REGN $BHVN $SPY Therma Bright Secures New Customer Initial Purchase Order, Signaling Market Confidence https://www.newsfilecorp.com/release/249651/Therma-Bright-Secures-New-Customer-Initial-Purchase-Order-Signaling-Market-Confidence
0 · Reply
newsfile_corp
newsfile_corp Apr. 24 at 11:35 AM
https://nfne.ws/249651 $TBRIF $THRM.TSXV @bright_therma #AIDigitalCoughTechnology #benepod #Inretio #interceptcs #venowave #Chemicals #Biot
0 · Reply
PsychedStocks
PsychedStocks Apr. 23 at 3:05 PM
$TBRIF rallying on strong demand for its innovative medical devices $ISRG $NVCR $BYSI $SPY
0 · Reply
PsychedStocks
PsychedStocks Apr. 23 at 1:26 PM
$TBRIF gaining traction after recent product approval $TDOC $CLOV $AMZN $SPY
0 · Reply
PsychedStocks
PsychedStocks Apr. 22 at 1:35 PM
$TBRIF accelerates with Venowave W5 breakthrough, lands purchase order for 1,750 units Poised to carve up a $1B market, Venowave's CMS reimbursement fuels growth Strategic shifts and partnerships setting industry abuzz - major shakeup ahead $MRNA $REGN $BHVN $GILD
0 · Reply
PsychedStocks
PsychedStocks Apr. 21 at 4:48 PM
$TBRIF loading up on InStatin—now owns ~20%. Inhaled statins for asthma & COPD. Asthma + COPD treatment market = $75B by 2034. $DRUG $LLY $CRSP $SPY
0 · Reply
PsychedStocks
PsychedStocks Apr. 17 at 12:55 PM
$TBRIF is reassessing its manufacturing strategy for the Venowave device due to recent U.S. tariff changes impacting Chinese-made goods. The company is exploring options including onshoring production to North America or adopting a hybrid model to mitigate costs and enhance supply chain resilience. Key considerations include lead times, quality control, IP protection, and logistics. This strategic review aims to ensure long-term competitiveness in the U.S. market
0 · Reply
PsychedStocks
PsychedStocks Apr. 17 at 12:52 PM
$TBRIF $GILD $REGN $MRNA $SPY Therma Bright Reviews Manufacturing Strategy in Light of US Tariff Changes https://www.newsfilecorp.com/release/248674
0 · Reply
PsychedStocks
PsychedStocks Apr. 17 at 12:50 PM
$TBRIF Therma Bright Inc. makes waves with Venowave VW5 poised for market domination. Venowave showcases 95% accuracy across 10 FDA-cleared uses, stepping into a vast $4B+ global market. $1M+ investment flows into $16B inhaled statin market, insiders bullish on 80% PREVA™ trial success $MRNA $REGN $BHVN $GILD
0 · Reply
newsfile_corp
newsfile_corp Apr. 16 at 10:30 AM
https://nfne.ws/248674 $TBRIF $THRM.TSXV @bright_therma #benepod #Inretio #InStatin #interceptcs #venowave #Chemicals #Biotechnology #Techn
0 · Reply
PsychedStocks
PsychedStocks Apr. 15 at 1:51 PM
$TBRIF focused on innovative diagnostic tests gaining traction. $DGX $LH $QQQ $SPY
0 · Reply
PsychedStocks
PsychedStocks Apr. 14 at 1:54 PM
$TBRIF is heating up as Therma Bright reports increased demand for their health tech solutions $AMYT $DXCM $AAPL $SPY
0 · Reply